In the liver, TRAF3 contributes to hepatic cell death following ischemia/reperfusion injury and to hepatic steatosis following HFD (high-fat diet)-induced diabetes, in part, through promotion of via TAK1-MKK-JNK signaling [21,54]. Here, MAPK8 is linked to fatty liver disease.